Strategic Oncology Account Director - New England/Upstate New York GSK plcStrategic Oncology Account Director - New England/Upstate New YorkPortland, ME$186,750–$311,250 / yearOwn enterprise-level relationships and lead on access strategies for our products for priority accounts, mapping influence hierarchies across academic cancer centers, IDNs and community practice networks and keep updated regularly. This role requires fluency across clinical science, real-world evidence, healthcare economics, and oncology practice operations-and the executive presence to engage C-suite, clinical leadership, and pharmacy decision makers with equal credibility.
Public Service Executive II - EUT Director State of MainePublic Service Executive II - EUT DirectorAugusta, Maine$88,628.80–$125,611.20In collaboration with the Commissioner and the senior leadership team, this position provides leadership in strategic planning and in clearly articulating the mission and priorities of the Office of Education in the Unorganized Territory necessary for the effective and efficient operations of multiple programs and schools of the office. The primary focus of this leadership position is to collaborate and provide strategic planning and operational leadership for the Office of Education in the Unorganized Territory and serves as the Unorganized Territory's Superintendent of Schools.
Director, Medical Science Liaison Boston, RI, RH, VT, ME Revolution Medicines IncDirector, Medical Science Liaison Boston, RI, RH, VT, MEAugusta, MERemote$236,000–$259,000 / yearKey aspects of this role will include engage in peer-to-peer scientific dialogue with healthcare professionals that translate into meaningful insights, serve as a therapeutic expert and thought partner to internal teams, liaison between Revolution Medicines and clinical study sites / investigators, and provide support for medical education, advisory boards, and medical congresses. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development.
Director End to End Process- Business Transformation Delhaize America, LLCDirector End to End Process- Business TransformationMECategory/Area of Expertise: Strategy Job Requisition: 498635 Address: USA-ME-Scarborough-145 Pleasant Hill Rd Store Code: ADUSA Executive Administration (5165705) Ahold Delhaize USA, a division of global food retailer Ahold Delhaize, is part of the U.S. family of brands, which includes five leading.